BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10652412)

  • 1. Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
    Hannah A; Feigen M; Quong G; Akhurst T; Berlangieri SU; Zimet A; Zalcberg J; McKay WJ; Scott AM
    Otolaryngol Head Neck Surg; 2000 Feb; 122(2):304-6. PubMed ID: 10652412
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract]   [Full Text] [Related]  

  • 4. Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
    Pawlik TM; Erasmus JJ; Truong MT; Macapinlac H; Ross MI; Gershenwald JE
    AJR Am J Roentgenol; 2006 Jul; 187(1):W117-9. PubMed ID: 16794124
    [No Abstract]   [Full Text] [Related]  

  • 5. PET detection of melanoma metastases in lymph nodes.
    Wagner JD
    J Nucl Med; 2003 Mar; 44(3):486. PubMed ID: 12621020
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging in melanoma and lymphoma.
    Abella-Columna E; Valk PE
    Semin Roentgenol; 2002 Apr; 37(2):129-39. PubMed ID: 12134366
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
    Hoffmann M; Oberhuber G; Kletter K; Becherer A; Raderer M
    Clin Nucl Med; 2002 Oct; 27(10):731-2. PubMed ID: 12352119
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of unsuspected metastasis in a melanoma patient with positron emission tomography.
    Argenyi EE; Dogan AS; Urdaneta LF; Ponto LL; Hichwa RD; Watkins GL
    Clin Nucl Med; 1995 Aug; 20(8):744-7. PubMed ID: 7586890
    [No Abstract]   [Full Text] [Related]  

  • 10. Unexpected breast metastasis from cutaneous melanoma on
    Martínez-Amador N; Martínez-Rodríguez I; García-Castaño A; Jiménez-Bonilla J; Quirce R; Banzo I
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):390-391. PubMed ID: 29625783
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
    Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H; Vihinen P
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract]   [Full Text] [Related]  

  • 14. Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging.
    Strobel K; Skalsky J; Hany TF; Dummer R; Steinert HC
    Clin Nucl Med; 2007 Mar; 32(3):213-4. PubMed ID: 17314600
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymph node false-positive FDG-PET after recent surgery in primary melanoma.
    Redondo P; Boán JF
    Acta Derm Venereol; 2004; 84(1):84-5. PubMed ID: 15040492
    [No Abstract]   [Full Text] [Related]  

  • 16. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
    Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
    J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic melanoma with multiple small bowel intussusceptions.
    Slaby J; Suri U
    Clin Nucl Med; 2009 Jul; 34(7):483-5. PubMed ID: 19542966
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
    Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the literature for whole-body FDG PET in the management of patients with melanoma.
    Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly growing pulmonary ground-glass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT.
    Dalpiaz G; Asioli S; Fanti S; Rea G; Marchiori E
    J Bras Pneumol; 2018 Apr; 44(2):171-172. PubMed ID: 29791543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.